Actively Recruiting
Efficacy and Safety of Photodynamic Therapy for CIN3
Led by Peking University Third Hospital · Updated on 2025-06-06
100
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To investigate the efficacy and safety of photodynamic therapy (20% 5-amino-ketovalerate 630nm red light) in the treatment of cervical intraepithelial neoplasia 3(CIN 3)in women in the real world
CONDITIONS
Official Title
Efficacy and Safety of Photodynamic Therapy for CIN3
Who Can Participate
Eligibility Criteria
You may qualify if you...
- CIN3 diagnosis requiring photodynamic therapy
- Type 1 or 2 transformation area confirmed by colposcopy
- Lesion boundary is completely visible
- Endocervical curettage (ECC) does not show high-grade lesions
You will not qualify if you...
- Presence or suspicion of cancer
- TCT test showing high-grade squamous intraepithelial lesion (HSIL)
- Lesion involving glands
- History of porphyria or suspected allergy to red and blue light
- Severe medical comorbidities
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking Unniversity Third Hospital
Beijing, China, 100191
Actively Recruiting
Research Team
Q
Qin Han
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here